| Anticoagulants in coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 18929235 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Anticoagulant therapy for acute coronary syndromes is becoming more complex as newer agents are added to unfractionated heparin and warfarin. The anticoagulants used in current clinical practice are low molecular weight heparins, direct thrombin inhibitors, and heparinoids. Properties of and recent clinical trial data regarding these newer anticoagulants are reviewed in reference to current American College of Cardiology/American Heart Association guidelines. |
| | |
Authors:
|
L Veronica Lee |
Related Documents
:
|
16466335 - Possible effect of thyroid function on anticoagulant response to unfractionated heparin. 18317045 - New british and american guidelines for the antibiotic prophylaxis of infective endocar... 9680105 - Evidence for sinoatrial blockade associated with high dose cytarabine therapy. 3929705 - Coronary bypass surgery in patients with circulating lupus anticoagulant. 16286175 - Cardiac resynchronization therapy improves heart rate profile and heart rate variabilit... 2970775 - Left ventricular function after successful percutaneous transluminal coronary angioplas... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cardiology clinics Volume: 26 ISSN: 1558-2264 ISO Abbreviation: Cardiol Clin Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2008-10-20 Completed Date: 2009-02-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8300331 Medline TA: Cardiol Clin Country: United States |
Other Details:
|
Languages: eng Pagination: 615-28 Citation Subset: IM |
Affiliation:
|
Division of Cardiology, Yale University School of Medicine, 789 Howard Avenue, FMP3, New Haven, CT 06437, USA. lveronica.lee@yale.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Coronary Syndrome
/
drug therapy* Angina, Unstable / drug therapy* Anticoagulants / pharmacology, therapeutic use* Antithrombins / therapeutic use Electrocardiography Heparin / therapeutic use Heparin, Low-Molecular-Weight / therapeutic use Heparinoids / therapeutic use Humans Myocardial Infarction / drug therapy*, physiopathology Thrombolytic Therapy Thrombosis / prevention & control |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Antithrombins; 0/Heparin, Low-Molecular-Weight; 0/Heparinoids; 9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythm...
Next Document: Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronar...